巴西获得银屑病生物制剂治疗5年后的认知：一项横断面研究数据集

数据集获取（Figshare）

• 源站标题：Perceptions over biologics for psoriasis after 5 years of access in Brazil: a cross-sectional study
• DOI：10.6084/m9.figshare.31408730.v1
• 发布日期：2026-02-25
• 文件数：3 个
• 文件总体积：45.72 KB
• 源站页面：https://tandf.figshare.com/articles/dataset/Perceptions_over_biologics_for_psoriasis_after_5_years_of_access_in_Brazil_a_cross-sectional_study/31408730

命令行下载

curl -L -o "ijdt_a_2627719_sm6706.docx" "https://ndownloader.figshare.com/files/62143931"
curl -L -o "ijdt_a_2627719_sm6703.docx" "https://ndownloader.figshare.com/files/62143934"
curl -L -o "ijdt_a_2627719_sm6701.docx" "https://ndownloader.figshare.com/files/62143937"

文件清单

• ijdt_a_2627719_sm6706.docx（15.80 KB）
• ijdt_a_2627719_sm6703.docx（15.47 KB）
• ijdt_a_2627719_sm6701.docx（14.44 KB）

文件总体积 45.72 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Biologic therapies have transformed psoriasis management, and their incorporation into Brazil’s public healthcare system (SUS) in 2019 expanded access nationwide. However, real-world utilization and perceptions remain incompletely understood.
To evaluate perceptions, barriers, and prescription patterns regarding biologic therapy among Brazilian dermatologists and patients five years after universal incorporation, while quantifying the prevalence of undertreatment.
We conducted two independent cross-sectional online surveys throughout 2024 among dermatologists (n = 225) and patients with psoriasis or psoriatic arthritis (n = 1,001). Data on demographics, clinical characteristics, and perceived barriers were analyzed.
Overall, 64.9% of dermatologists prescribed biologics, with higher prescribing rates among younger physicians (p = 0.022), those with fewer years of practice (p = 0.013), higher patient volumes (p p = 0.001). Only 25.5% of patients were receiving biologics, strongly associated with psoriatic arthritis (p Persistent educational and structural barriers continue to limit optimal biologic use despite formal availability, highlighting the need for targeted education, streamlined care pathways, and improved physician–patient communication to achieve equitable outcomes.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.31408730.v1（source: https://tandf.figshare.com/articles/dataset/Perceptions_over_biologics_for_psoriasis_after_5_years_of_access_in_Brazil_a_cross-sectional_study/31408730）。